Compare AUDC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUDC | ATYR |
|---|---|---|
| Founded | 1992 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.7M | 49.2M |
| IPO Year | 2000 | 2015 |
| Metric | AUDC | ATYR |
|---|---|---|
| Price | $10.93 | $0.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $2.86 |
| AVG Volume (30 Days) | 87.5K | ★ 2.7M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.75% | N/A |
| EPS Growth | N/A | ★ 6.98 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $190,000.00 |
| Revenue This Year | $3.05 | N/A |
| Revenue Next Year | $3.87 | N/A |
| P/E Ratio | $23.06 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.95 | $0.27 |
| 52 Week High | $10.86 | $1.12 |
| Indicator | AUDC | ATYR |
|---|---|---|
| Relative Strength Index (RSI) | 63.22 | 26.30 |
| Support Level | $8.14 | N/A |
| Resistance Level | $10.86 | $0.59 |
| Average True Range (ATR) | 0.28 | 0.03 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 90.98 | 17.58 |
AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).